Cardio Exam 1 Flashcards

1
Q

Talk through Wigger’s diagram

A

Do it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does CVP (central venous pressure) measure?

A

Ability of heart to pump blood out of RA - determined by tricuspid valve function, RV function, pulmonary arterial function etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common causes of increased CVP

A
  1. Heart failure 2. Tricuspid valve disorders 3. Pulmonary arterial HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cause of decreased CVP

A

Low blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss JVP wafeforms

A

A: Atrial systole X: fall in RA pressure after a wave peak C: ventricular contraction, tricuspid valve Closure X’: descent of cardia base after atrial relaXation V: venous filling of RA Y: rapid ventricular filling - right atrium is emptYing H: continued filling of right atrium during diastole that is inte4r

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which jugular vein is more directly related to changes in RA pressure/heart?

A

RIJ REJ is more superficial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does high A wave from jugular pressure waveform indicate?

A
  • Stenosis of tricuspid - Closure of tricuspid valve - Right ventricular failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does distension of jugular vein indicate?

A

severe congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does S1 reflect?

A

mitral and tricuspid closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does S2 reflect?

A

aortic and pulmonic valve closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Between S1 and S2 heart sounds, which sound varies with respiration?

A

S2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What cardiac event occurs between S1 and S2? Between S2 and the next S1?

A

Systole between S1 and S2 Diastole between S2 and the next S1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe physiologic splitting of S2

A

With inspiration, there is increase venous return to RV = increased RV EDV = increased time to expel blood from RV = pulmonic valve stays open longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Common causes of widened S2 splitting? Not the physiologic splitting.

A
  • RBBB (delay in RV contraction = delay in closure) - Pulmonic stenosis (more time to open, delay in closing) - Also COPD: increased back pressure into RV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common cause of fixed splitting of S2?

A

ASD Pulmonary side of heart has low resistance, so volume overload in right heart results in delayed closure of pulmonic valve. These individuals don’t have physiologic splitting with respiration. It is just fixed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common causes of paradoxical splitting?

A

This just means that pulmonic closes before aortic and this occurs during expiration, not inspiration. LBBB (delay in LV contraction = delay in aortic valve closure) Aortic stenosis (more time open, delay in closure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What sound is heard during mitral stenosis? When does sound occur?

A

Opening snap Why? Calcification and stiffening valve. Note: sound is fixed and occurs at the start of diastole (before S1). No change with respiration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Is S3 pathologic? Why and when does it occur?

A

Produced by tension of chordae tendinae during rapid filling of diastole. Can be seen in young with thin chest wall and supple ventricle - also in athletes. No pathology here. Can be seen in pathology - volume overload or advanced regurg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is 4th heart sound? Why and when does it occur?

A

Occurs in late diastole and coincides with atrial contraction. It is a pre-systolic sound produced when trying to fill a stiff ventricle. Heard in cases of low ventricular compliance, hypertrophy and acute MI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Murmurs heard in aortic area

A

Ejection type murmurs such as: Aortic stenosis Flow murmur?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Murmurs heard in pulmonic area

A

Ejection type murmurs such as: Pulmonic stenosis Flow murmur?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Murmurs heard in tricuspid area

A

Pansystolic murmurs such as: Tricuspid regurg VSD Also mid-to-late diastolic murmurs such as Tricuspid stenosis ASD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Murmurs heard in mitral area

A

Pansystolic murmurs such as Mitral regurg Also mid-to-late diastolic murmurs such as Mitral stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Types of systolic murmurs

A
  1. Ejection type: aortic stenosis, pulmonic stenosis. Sound here = crescendo, decrescendo 2. Pansystolic (holosystolic): mitral regurg, tricuspid regurg, VSD Sound here = non-crescendo/decrescendo sound 3. Late systolic: MVP Sound here = mid-systolic click with non-crescendo/decrescendo sound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Murmurs heard at left-sternal border (Erb’s point)

A

Early diastolic murmurs: Aortic regurg Pulmonic regurg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

CO calculation. What is normal value in resting adult?

A

CO = SV.HR Normal ~5L/min in resting adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Define cardiac index

A

Volume of blood ejected from heart per unit time per unit of body surface area eg. 3L/min/m^2 This is more realistic parameter of cardiac function as it takes into account the size of the human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How much of the SV is attributed to rapid filling phase? How about atrial kick/contraction?

A

~ 80% by rapid filling - passive ~ 20% by atrial contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Define preload Define afterload

A

Preload: Tension exerted on the cardiac ventricular muscle when it begins to contract Afterload: pressure that ventricle has to win to produce a stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What happens to SV as preload increases if all other factors are equal? How can this principle be used in patient with heart failure? What must you be careful of?

A

SV increase within certain limits. Pt with heart failure can have decreased CO. If you want to increase it, you can IV bolus them especially if dehydrated. As you do, BP should go up. Too much can cause patient to go into pulmonary edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe Frank-Starling relationship and mechanism

A

Relationship: force of ventricular contraction is function of ventricular end diastolic length. If you increase pre-load, contractility and ultimately SV increases. Mechanism: length of sarcomere determines sensitivity to Ca. There is optimum. Within limits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What happens to SV with increasing afterload if all else is equal?

A

Increase afterload results in decrease in SV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the ANREP relationship and mechanism? Why do I care?

A

Relationship: increase in aortic pressure abruptly = positive inotropic (FOC) effect. Mechanism: increase LV wall tension = increase cytosolic Na level, increase myocardial cytosolic Ca level = increase myocardial contraction. Why do I care? If I want to hear a particularly soft murmur, I can apply a torniquet or have someone make fist to increase work of heart and therefore sound of murmur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What happens to SV when ventricular contractility goes up with all other factors being equal?

A

Increased contractility = increased SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Review SV vs preload, afterload, contractility graphs

A

do it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Review contractile status, ventricular performance graph

A

do it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is Bowditch effect/phenomenon?

A

Increased HR progressively enhances FOC. If too rapid, force decreases. CO is rate-dependent. Makes sense if you remember CO = SV.HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Clinical method of measuring CO

A

Pulmonary artery catheterization (PAC): thermodilution with bolus injection of cold fluid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

The cardiac AP contour looks the same as skeletal muscle AP contour?

A

Falsch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Describe the cardiac myocyte AP curve. Include the phases, ions/channels responsible for the changes

A

Depolarization = phase 0 - Opening of fast Na = rapid depolarizing Early repolarization = phase 1 - Na channels close, some K channels open, incomplete repolarization Plateau = phase 2 - Membrane potential ~ 0 mV (ECG!!). Slow Ca channels open = Ca in, balanced by opening of K channels allowing K out Rapid repolarization = phase 3 - Ca channels close, opening or more K channels = K out RMP = phase 4 - Only K channels and maintenance Na/K ATPases open allowing for maintenance of RMP until next stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Describe cardiac nodal tissue AP

A

* note: only phases 0, 3 and 4; no 1, 2 Phase 0: Threshold met = opening of Ca channels slowly Phase 3: After depolarization occurs, K channels open, K out Phase 4: HCN/funny current channels slowly depolarizes cell - progressive reduction in K efflux and progressive increase in calcium influx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is the difference between channels responsible for depolarization in cardiac myocytes and cardiac nodal tissue?

A

Cardiac myocytes: Fast Na channels Cardiac nodal tissue: Ca channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Describe sequence of depolarization in heart. Note the order of depolarization within the ventricles.

A

SA node Atria AV node Bundle of His Bundle branches Purkinje fibers Ventricles: Septum, apex and ventricular free walls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Approximate rates of conducting tissue in heart

A

SA node: 60-100 AV: 40-55 Bundle of His, Bundle branches, Purkinje: 25-40 Note: atrial and ventricular myocardium don’t have pacemaker rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Which lead on ECG shows greatest net depolarization of heart?

A

Lead II - greatest deflection 60 degrees

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

The refractory period of the AP in cardiac myocytes is related to which of the following ion channels: a. Sodium channels b. calcium channels c. potassium channels d. chloride channels

A
  • Answer = A. Fast Na channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What are the two refractory periods seen in cardio myocyte AP cycle? What is happening to cause these periods? Can additional stimulus elicit AP during each of these periods?

A

Absolute refractory period Relative refractory period These are a result of the gating kinetics of the fast Na channel found in cardiac myocytes that exist in 3 states: a. Resting: no Na entering cell as inner pore is closed, intracellular gate is open. b. Activated: stimulus lead to VG change and opening of VG sensitive inner pore. Na enters cell. c. Inactivated: intracellular gate closes and Na ceases to enter cell even though inner pore is open. ARP: cannot illicit another AP regardless of strength of stimulus as intracellular gate is closed, despite inner pore being open RRP: can illicit another AP is strength of stimulus is sufficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Why is there a time delay between electrical events in cardiac myocytes and mechanical response in the tissue?

A

Takes some time for Ca channels to open. This causes the delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Describe events of cardiac myocyte contraction and relaxation

A

Contraction: - Calcium entry through VOCC - Calcium release from SR (through ryanodine receptor) - Calcium interacts w/trop = contractile shortening Relaxation: - Calcium dissociates from trop - Ca taken back up into SR via SERCA (atpase) - Ca becomes bound to proteins within SR (calcisequestrin) - CA pumped out of cell at cell membrane via NCX (Na/Ca exchanger atpases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Types of arrhythmogeneses

A
  1. Active a. Automaticity b. Triggered activity: Early afterdepolarizations, After depolarizations d. Re-entrant circuits 2. Passive a. Cardiac remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Describe arrhythmias from automaticity

A

These are arrhythmias from cells with phase 4 depolarization. SA node can lead to sinus tachy (via SNS increases automaticity) and sinus brady (via PSNS decreasing automaticity). These are obviously physiologic arrhythmias. Subsidiary or latent pacemakers can be found in atria, AV junction, ventricles. This is abnormal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Diastolic depolarization underlies a major difference in channel expression between nodal and non-nodal cells. What ion channels are not present in non-nodal tissue? a. Calcium ATP-ases b. Na-K ATPases c. Na-Ca exchanger d. Hyperpolarization-activated cyclic nucleotide-gated channels e. Beta-adrenergic receptors

A

Answer = D. HCN/funny current channel active during phase 4 depolarizations seen in cardiac nodal tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Effect of Ach on phase 4

A

Increases K efflux = reducing slope of phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Effect of NE on phase 4

A

Increase Ca and funny current = increase slope of phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Effect of hypokalemic on phase 4

A

Decrease K current = increase in slope of phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Effect if ischemia on phase 4

A

Decrease K current = increase in slope of phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Effect of mild hyperkalemia on phase 4. Severe hyperkalemia?

A

Mild hyperkalemia = increase in max diastolic potential = increase in slope of phase 4 Severe hyperkalemia = significantly depolarized membrane potential, cells become inexcitable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Describe how triggered activity leads to development of arrhythmogenesis? What ions are responsible for DAD and EAD? Which is exacerbated by low HR? Which by high HR?

A

This refers to eliciting AP changes in cells without phase 4 depolarization, ie. myocytes. DAD: cytosol and / or SR becomes Ca overloaded resulting in change in membrane potential leading to AP. Exacerbated by high HR. Why? Interrupts ability to recycle Ca. EAD: any alterations in any ion flux during plateau phase (2) or phase 3 leading to prolonged AP duration and generation of AP. Specifically: reduced K current, increased Ca, increased Na/Ca exchange activity, increased late Na current. Exacerbated by low HR. Why? APs tend to be long at low HRs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Types of re-entrant circuits. Which are harder to tx? Which have worse prognosis?

A

Anatomically: WPW syndrome, AVNRT, atrial flutter, PSVT. Tx with ablation. More easier to tx, better prognosis. Functionally: absence of defined pathway. Harder to tx. Worse prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Describe how cardiac remodeling leads to arrhythmogenesis

A

Changes in gap junctions Changes in cell structure: fibrosis, fat, nerve endings, cell hypertrophy Strength of impulse now acts on smaller amount of tissue = length of AP increased now.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Effect of PSNS on blood vessels, heart and coronary arteries

A

BV: no innervation by PSNS Heart: decrease HR and contractility Coronary arteries: constrict Cranial: 10, 9, 7, 3 Sacral: S2-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Effect of SNS on blood vessels, heart and coronary arteries

A

BV: constriction (except skeletal) Heart: increase HR and contractility Coronary arteries: dilate Ganglia: T1-L2 Cervical ganglia Lumbar splanchnic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Result of flattened diaphragm on CO

A

Decreased CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Viscero-somatic reflexes for heart

A

SNS: T1-5 left PSNS: OA (vagus)

65
Q

How do somatic dysfunctions lead to cardiac dysfunction?

A

Head and neck = T1-4 SNS ganglia are from T1-L2 with close relationships to rib heads SNS cervical ganglia superior at C2/3, middle at C6 and inferior at C7. These target head, heart, neck etc. PSNS is primary vagus which emeres from jugular foramen located between occiput and temporal bones. Ultimately: pain stimulates the SNS nervous system = heightened response on something already potentially overstressed.

66
Q

What are the somatic presentations of visceral problems at heart?

A

Left-sided chest, left shoulder and arm, jaw, neck, epigastric, back and rib pain.

67
Q

Left SNS fibers to heart innervate what? What does hyperactivity of these fibers lead to?

A
  • innervate deep cardiac plexus and AV node - ectopic foci and v fib
68
Q

Right SNS fibers to heart innervate what? What does hyperactivity of these fibers lead to?

A
  • innervated deep cardiac plexus and SA node - supraventricular tachyarrhythmias
69
Q

Left vagus innervates what in the heart? What does hyperactivity of these fibers lead to?

A
  • AV node - AV block
70
Q

Right vagus innervates what in the heart? What does hyperactivity of these fibers lead to?

A
  • SA node - Sinus bradyarrhythmias
71
Q

Lymphatic drainage from the heart and lungs is carried by what? Impaired drainage could lead to what conditions?

A

Left thoracic duct Conditions: reduction in collateral circulation (ischemia and infection), atherosclerosis, HTN, CHF, electrolyte imbalance

72
Q

At what angle of scoliosis does cardiac function deteriorate

A

> 75%

73
Q

What are the spinal levels/viscero-somatic relationships for: - ventricles - atria - anterior MI - posterior/inferior MI

A

Do we need to know? - Ventricles: C8-T3 - Atrial: T4-T6 - Anterior MI: left T1-4 - Posterior/inferior MI: C2 and cranial base (OA)

74
Q

For CHF, what OMM treatments should be emphasized?

A

Lymphatic treatments

75
Q

OMM treatment for essential HTN

A

Tx kidneys and adrenals to decrease hydrostatic pressure gradient across filtration membranes of glomerula of kidneys. This is T10-12.

76
Q

Anterior LV MIs are best viewed in what leads?

A

Precordial leads, I and aVL

77
Q

Inferior LV MIs are best viewed in what leads?

A

Leads II, III and aVF

78
Q

The heart is perfused primary during what phase of cardiac cycle? a. ventricular systole b. ventricular diastole c. isovolumic contraction d. isovolumic relaxation

A

Answer = B - rapid filling during ventricular diastole

79
Q

What happens to coronary blood flow as LV pressure increases?

A

Sharp decrease because BVs are squashed

80
Q

Systolic compression of coronary blood vessels is worst in which side of heart?

A

Left heart > right heart. Why? left has to generate more pressure to overcome systemic pressures.

81
Q

Flow equation. Using this, how does coronary perfusion/flow remain constant given changes in pressure?

A

Flow = delta P / R Blood flow maintained through changes to R. Think mathematics and physics here. If decrease in pressure, flow is maintained through reducing resistance within coronary vessels. They change in same direction.

82
Q

What is coronary reserve? Why do I care?

A

It is the different between passive movement (capacity of vessels) due the pressure of blood and the autoregulatory curve (BV maintaining tension). This is related to how well vessels can vasodilate. Why care? If there is impaired vasodilation to vessels (eg. endothelial dysfunction leads to inability to produce NO) then coronary reserve decreases. Individuals cannot exert themselves as vasodilation isn’t functioning properly.

83
Q

What is the relationship between myocardial o2 consumption and blood flow?

A

As coronary blood increases, o2 consumption increases.

84
Q

Describe how coronary circulation is regulated by metabolism?

A

Increase in metabolism = Increase in hypoxia (not pathologic yet) = Increase in ATP turnover (use outpaces production) = Increase in cellular adenosine accumulation = Adenosine diffuses out of cell and acts on vascular adenosine receptor = Vasodilation

85
Q

Does hypoxia induce vasodilation or vasoconstriction in cardiac blood vessels? What mediates this?

A

Vasodilation. Mediated by adenosine.

86
Q

Describe two phases of SNS regulation of coronary circulation

A

1st phase: transient vasoconstriction (d/t direct effect of NE on alpha-1 receptors) 2nd phase: SNS drives increase HR and FOC = hypoxic vasodilation

87
Q

Describe pulmonary circulation in terms of resistance and capacitance

A

High capacitance (can hold a lot of blood) Low resistance (compared to systemic)

88
Q

Compare resistance between right outflow and left outflow of heart

A

Right side = low resistance Left side = high resistance

89
Q

Between the apex and the base of the heart, describe in terms of pressure “cost” - where is it easier to get blood? What is the implication in terms of lymphatic drainage?

A

Zone 1 (apex): higher pressure cost Zone 3 (base): lower pressure cost Ultimately easier to perfuse base of lungs. Increase in capillary hydrostatic pressure higher at base. Requires lymphatics to function well. If fluid in lungs, crackles heard in lower part first.

90
Q

Hypoxia leads to what response in pulmonary vasculature?

A

Vasoconstriction.

91
Q

Why alter pulmonary circulation?

A

Match VQ

92
Q

Describe passive regulation of pulmonary circulation

A

Recruitment: opening of previously closed capillaries through higher perfusion pressure Distension: accommodation of increased blood volume in capillaries Gravity, body position, lung volume etc.

93
Q

What are the causes and responses to alveolar hypoxia?

A

Causes: airway obstruction, high altitude, acute lung damage, COPD Low o2 alveolar partial pressure = ? signal = constriction of adjacent blood vessels that are hypoventilated = blood diverted = decreased wasted ventilation areas.

94
Q

Results of chronic hypoxemia in lungs

A

Hypoxic vasoconstriction = increased resistance to flow, hypoxia stimulates vascular SMC hypertrophy = increased pulmonary pressure = (pulmonary arterial HTN) RVH = RV dilation, valve damage = RV failure

95
Q

Commonly used classification system of anti-arrhythmic drugs

A

Vaughn-Williams system

96
Q

Describe Vaughn-Williams classification system - list class, MOA and drugs

A

IA: quinidine, procainamide, disopyramide MOA: moderate Na channel blocking IB: lidocaine, mexilitene MOA: mild Na channel blocking IC: flecinide, propafenone MOA: marked Na blocking II: metoprolol, atenolol MOA: beta-blocking III: sotolol, amiodarone, ibutililde MOA: K blocking. Amiodarone has Na, Ca, K and beta-blocking effect IV: verapamil, diltiazem MOA: CCB

97
Q

Quinidine. Use, MOA, adverse effects

A
  • Use: old drug, previously used for ventricular arrhythmias - MOA: class IA, Na channel blocker - Adverse effects: AV block, Torsades (prolong QT), GI upset, Cinchonism
98
Q

Procainamide. Use, MOA, adverse effects, what is important about pharmacokinetics

A
  • Use: previously used for ventricular arrhythmias - MOA: class IA, Na channel blocker - Adverse: QT prolongation, lupus - Pharmacokinetics: NAPA = active metabolite (ability to make is pharmacogenetically determined)
99
Q

What is common adverse effect of class IA antiarrhythmic drugs?

A

QT prolongation

100
Q

Disopyramide. Use, MOA, adverse effects, what is important about pharmacokinetics

A
  • Use: previously used for ventricular arrhythmias, may be more effective in atrial arrhythmias - MOA: class IA, Na channel blocker - Adverse: potent anticholinergic effects - Pharmacokinetics: renal and hepatic excretion, must watch dose in kidney failure patients
101
Q

Lidocaine. Use, MOA, adverse effects, what is important about pharmacokinetics of this drug?

A
  • Use: prevention/tx of VT / VF especially during ischemia - effective in preventing re-entrant rhythms (not first line in ACLS) - MOA: class IB, Na channel blocking - Adverse effects: CNS effects at toxic levels, Can give to patients allergic to procaine as this is amide, not ester, AV block rare - Pharmacokinetics: can monitor for toxicity
102
Q

Flecainide. Use, MOA, adverse effects

A
  • Use: SVTs in patients with normal cardiac function (never in ischemic heart dz, CAD or heart failure) - MOA: class IC, Na channel blocking (potent) - Adverse: drugs caused increased mortality in those with post-MI arrhythmias, well tolerated generally
103
Q

Propafenone. Use, MOA, adverse effects

A
  • Use: prevent/convert SVT, VT, VF (in pt without underlying heart disease) - MOA: class IC, Na channel blocking (potent), some beta-blocking - Adverse: fairly well tolerated, not for use in pt without underlying heart disease, can cause torsades, AV block, CHF. Must reduce dose of digoxin or warfarin when using this.
104
Q

Which class of anti-arrhythmic drugs cause increase in mortality?

A

All class I. Can use class IC in patients with arrhythmia provided they don’t have underlying heart disease. Rare to use these drugs. This includes flecainide and propafenone.

105
Q

Which is the only class of antiarrhythmic drugs that have been found to reduce mortality in arrhythmia patients?

A

Beta-blockers (class II)

106
Q

Sotolol. Use, MOA, adverse effects

A
  • Use: prevention of AF and sustained VT/VF - MOA: beta-adrenergic blocking with class III properties - Adverse: Torsades! (prolongs QT in dose dependent fashion - monitor), Bronchospasm
107
Q

What is the typical first drug used by cardiologists for patients to prevent AF and sustained VT/VF?

A

Sotolol

108
Q

Amiodarone. Use, MOA, adverse effects, what is unique about pharmacokinetics for this drug

A

Must know!!! - Use: prevention of SVT esp Afib, VT and VF (1st line in ACLS) - MOA: Na, Ca, K and beta-blocking effect. Class III - prolongs AP duration and ERP - Adverse effects: a. Pulmonary fibrosis (most feared side effects, but takes years) b. Thyroid (hypo mostly, but also hyper) - drug is largely composed of iodine. Give L-thyroxine if hypothyroidism develops. If hyper, switch to different drug. c. Ocular d. Neurologic: tremor, seizures, etc. e. Derm: irreversible blue-green discoloration (smurf-drug), photosensitivity f. Hepatic and GI g. Basically interacts with all drugs until proven otherwise! ** Must monitor via CXR, EKG, LFTs, TFTs, etc. - Pharmacokinetics: has high Vd (60L/kg!) and gets into most everywhere in the body. Has long half life up to 120 days.

109
Q

What is the 1st line ACLS drug to prevent SVT (aF), VT and VF?

A

Amiodarone

110
Q

Can amiodarone be used in CHF patients? Dronaderone.

A

Can use amiodarone in CHF patients. Dronaderone is contraindicated.

111
Q

Dronaderone. Use, MOA, adverse effects

A

*Class III derivative of amiodarone with replacement of iodine - Use: AF (not as effective as amiodarone) - MOA: class III, all channel blocking? - Adverse effects: contraindicated in severe CHF. Milder than amiodarone (no serious skin, pulmonary, thyroid problems).

112
Q

Dofetilide. Use, MOA, adverse effects

A
  • Use: conversion and maintenance of AF, option for pts with LV dysfunction, relatively safe in CHF - MOA: ? - Adverse effects: high incidence of Torsades (even higher than sotalol)! Newer drug: 3 day inpatient stay with initiation of drug, only registered physicians may prescribe, only 1 mail-order pharmacy authorized to dispense
113
Q

What is the standard treatment for most ventricular arrhythmias?

A

ICD: implantable cardioverter defibrillator. Much better than drugs.

114
Q

What drugs are used to tx Afib in the following patients: a. A fib with no other heart dz? b. A fib with hx of CAD, but normal EF? c. A fib with CHF?

A

a. Flecainide, propafenone b. Sotolol c. amiodarone or defetilide

115
Q

Rate-control drugs

A

Beta-blockers, diltiazem, digoxin

116
Q

Define atherosclerosis

A

Progressive, chronic inflammatory disease of large arteries that starts in childhood and progresses rapidly in third decade or later in life. Involves intima of vessels.

117
Q

Pathogenesis and various hypotheses of atherogenesis

A

Current hypothesis: - Endothelial cell injury induced by hypercholesterolemia, disturbed flow, or other factors - ECs over-expression VCAM which increase cellular adhesion & recruit inflammatory cells - Macrophages arrive: plasma LDL undergoes modification or oxidation by them. Oxidized is cytotoxic. - MCP-1 (monocyte chemo-attractant protein-1) recruits monocytes - Proliferation of SM cells - Activated macrophages release additional cytokines. - Foam cells: macrophages and SM cells packed with droplets of cholesterol esters. These secrete many factors contributing to the inflammatory process. know cell players: endothelial cells, smooth muscle cells, macrophages, also platelets

118
Q

Histology of atherosclerosis

A

Histology (same as any chronic inflammation): infiltration by macrophages and lymphocytes, mesenchymal cell proliferation, fibrosis, cell necrosis, neovascularization. KEY: SM proliferation, accumulation of CT elements, lipid deposition

119
Q

Risk factors for atherosclerosis. Why are multiple risk factors bad?

A

Non-modifiable: increasing age, male, family hx, genetic abnormalities (hyperlipidemia etc.), chronic renal dz Modifiable: hyperlipidemia, HTN, CIGARETTE SMOKING (200% by smoking, cessation halves the increased risk), DM, CRP, inactivity, stress, obesity, maybe homocysteine? Multiple risk factors may impose more than additive effect, they are synergistic.

120
Q

Clinical features of atherosclerosis

A

Clinical features: MI, ischemic stroke, peripheral arterial dz, visceral infarction, atherosclerotic aneurysms

121
Q

What is the most important serum cholesterol component that increases risk for atherosclerosis?

A

LDL. Note: lipoprotein a is a significant risk factor independent of LDL

122
Q

Which dyslipoproteinemias lead to premature atherosclerosis? Which lead to severe? Which don’t lead to premature atherosclerosis?

A

No premature AS: type I = familial LPL deficiency (increases chylomicrons) Premature AS: - Type IIa: famililal hypercholesterolemia (high LDL) - Type IIb: familial combined hypercholesterolemia (high LDL and VLDL) - Type III: familial type III lipoproteinemia (high IDL) - Type IV: famililal hypertriglyceridemia (high VLDL and high TGs) Severe AS: - Type V: familial AI/CII deficiency - no HDL

123
Q

Characteristics lesions of atherosclerosis

A

Fatty streaks Proliferative lesions Fibrofatty plaques (aka atheromas)

124
Q

At what locations in vessels is atherogenesis more likely?

A

Arterial branch points where eddies and circular flow occur. Areas of low shear/and/or disturbed flow.

125
Q

Complications from atherosclerotic lesions

A

Calcification Hemorrhage Rupture (aneurysm) or ulceration Thrombosis (occlusion, stenosis)

126
Q

Which atherosclerotic plaques are vulnerable?

A

Soft w/lipid filled core. These are prone to rupture. Those with thick cap have reduced rupture risk.

127
Q

What is the earliest lesion in atherosclerosis?

A

Fatty streak

128
Q

Which atherosclerotic lesion is the bad guy?

A

Fibrous plaque

129
Q

What is considered positive family history risk factor for atherosclerosis?

A
  • Family history of premature CAD in a first degree relative (not aunt, uncles, cousin, grandparents). In male
130
Q

Most common cause of death in DM patient

A

Atherosclerosis and consequences thereof

131
Q

Diagnosis of metabolic syndrome

A

Requires any 3 of following: a. diabetic dyslipidemia b. primary arterial hypertension c. central abdominal obesity d. insulin resistance e. prevalence in CAD patients

132
Q

What would you tell your patient to encourage them to stop quitting to reduce the risk of atherosclerosis?

A

~ 50% reduction in year 1 by year 5 after smoking cessation, risk of CAD or MI approximates that of non-smokers

133
Q

Mechanisms of enhanced atherosclerosis due to smoking:

A
  • hemodynamic stress - endothelial injury & dysfunction - atherogenic lipid profile - enhanced coagulability - arrhythmogenesis - relative hypoxia (CO)
134
Q

Outcomes of coronary atherosclerosis

A
  • ACS: unstable angina (ischemia), MI - Sudden death (VT, VF) - Dilated (ischemic) cardiomyopathy - A fib/flutter
135
Q

Primary and secondary preventive therapies for coronary atherosclerosis

A

Primary: appropriate diet, regular exercise, optimum weight, stop smoking Secondary: tx dyslipidemias (statins), tx DM (goal: HgA1C

136
Q

Determinants of myocardial o2 demand

A

HR, contractibility, systolic wall tension

137
Q

Symptoms of myocardial ischemia

A

Chest discomfort referred to jaw, shoulder, ulnar L arm, most often exertional, DOE, nausea, other GI (someone who had intractable diarrhea)

138
Q

Differential diagnosis of chest pain

A

Costochondritis, GI (esophageal spasm, GERD, biliary colic), aortic dissection, pericarditis

139
Q

Symptoms of angina

A

heavy pressure, band-like, crushing lasts

140
Q

Stable vs unstable angina

A

Stable: same pattern, timing, severity, episodes Unstable: new onset, subjectively worse discomfort than with previous, onset with less activity, angina at rest (angina decubitus)

141
Q

PE findings of myocardial ischemia

A

May be normal Maybe: cardiomegaly, murmurs, S4

142
Q

Diagnosis of myocardial ischemia

A

Resting ECG Basic labs: lipids, basic chems, exercise stress testing, echo

143
Q

When should stress testing be performed?

A

Atypical chest discomfort

144
Q

Meds used to do pharm stress testing of heart

A

Adenosine and dipyridamole: vasodilate, increases HR and work Dobutamine: increase contractility

145
Q

What does ST depression mean?

A

Subendocardial ischemia

146
Q

What does ST elevation mean?

A

Full thickness ischemia

147
Q

When is stress testing highly predictive of myocardial ischemia?

A

Typical symptoms of angina OR ECG shows horizontal or downsloping of ST depression. With ST depression > 2mm, the diagnosis is certain!!!

148
Q

3 results of myocardial ischemia

A
  1. Myocardial infarction 2. Chronic ischemia w/o infarction 3. Relief
149
Q

Treatment of myocardial ischemia

A
  1. increase o2 supply: reperfusion (thrombolysis, PCI, CABG) coronary vasdilation (nitrates, dihydropyridines) 2. decrease o2 demand beta blockers (decrease HR, decrease contractility) decrease BP reduce preload (diuretics, nitrates) reduce circulating catecholamines (sit with patient, calm them down)
150
Q

Drug therapies for myocardial ischemia. How do they work in this case?

A
  • nitrates: decrease preload (venodilate), coronary dilations, enhanced endothelial function - beta blockers: decrease HR and contractility = decrease o2 demand, no effect on supply - CCBs: prevent spasm, reduction of afterload (vasodilating), some (verapamil, diltiazem) reduces contractility and / or HR, no change on preload (no venodilating)
151
Q

Functional classification of cardiomyopathies

A
  • Dilated: disorder of myocardial muscle resulting in dilation and weakening of the left ventricle - most common - Hypertrophic: disorders of myocardial muscle resulting in hypertrophy, left ventricular dysfunction and arrhythmias - Restrictive: group of disorders resulting in excessive myocardial stiffening with resultant ventricular dysfunction
152
Q

Define cardiomyopathy

A

group of diseases of varying etiologies in which the main feature is myocardial involvement

153
Q

What is meant by etiologic classfication?

A

inflammatory, metabolic, toxic, infiltrative, fibroplastic, hematologic, hypersensitivity, genetic, misc, idiopathic, physical agents

154
Q

Dilated cardiomyopathy. a. Etiologies b. How is it diagnosed? History? Sx? PE findings? Studies? c. Treatment of choice

A

a. Etiologies: Idiopathic, ischemic, hypertensive, ALCOHOLIC, infectious, metabolic b. Diagnosis - History: relates to etiology (angina, previous MI, HTN, etoh/toxins, foreign travel) - Sx (related to LV failure): fatigue, weakness, dyspnea (exertional, orthopnea, PND) - improves as RV fails, pale, tachy, also: anorexia, early satiety, abdominal fullness - PE: i. Signs of LV failure: tachy, pallor, dyspnea, apical life/thrill (apical), S3 universally present (overload), many different murmurs, P2 may vary ii. Signs of RV failure: elevated JVPs, cardiomegaly, RV life, P2 varies, RV and LV S3 universal (overload), various murmurs, pulsus alternans, hepatomegaly, splenomegaly, ascites, peripheral edema, evidence of poor nutrition - Studies: no specific ECG findings (maybe sinus tachy, voltage for LVH, LBBB, non-specific ST and T changes), CXR, radionuclide studies, cardiac cath, echo (chamber dilation, poor systolic function) c. Tx: reduce activity, restricted Na intake, drug: ACEIs = drug of choice Note: afib common finding with, must stop drinking

155
Q

Hypertrophic cardiomyopathy. a. Etiologies, types b. How is it diagnosed? Sx? PE findings? Studies? c. Treatment of choice

A

a. Etiologies: - Types (macroscopic): Asymmetric septal hypertrophy without obstruction, ASH with obstruction, concentric hypertrophy with obstruction, apical hypertrophy (rare) b. Diagnosis - Sx: young onset (avg 26), sudden death, dyspnea, angina, fatigue, syncope - PE: slight displaced bifid LV impulse (double bump), bisferiens (double bump) carotid pulse, S4 very common (myocardium incompliant), systolic murmur of variable qualities - Studies: ECG (increased voltage in anterior leads, ST and T wave changes, Q waves in inferior lateral, ventricular arrhythmias), echo are diagnostic (LV hypertrophy w/ various other things; chamber normal to small in size and shows nml contractility) c. Tx: reduce physical activity esp vigiours sports, pharm (beta blockers to decrease contractility which is a problem as it obstructs LVOT or: disopyramide, verapamil), myotomy/myectomy

156
Q

What is the hallmark of restrictive cardiomyopathy?

A

Hallmark is diastolic dysfunction

157
Q

Etiologies of restrictive cardiomyopathy

A

Processes that lead to material infiltrating heart tissue: amyloidosis, hemochromatosis, sarcoidosis, Loeffler’s endocarditis, endomyocardial fibrosis

158
Q

Do L18-19, 20, 23

A

Do L18-19, 20, 23